THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Anjan Pradhan to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Back to Details
This is a "connection" page, showing publications Anjan Pradhan has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Anjan Pradhan
Connection Strength
0.432
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  1. EVI1 targets platelet endothelial cell adhesion molecule and up-regulates its expression in chronic myeloid leukemia. Leuk Lymphoma. 2014 Apr; 55(4):954-6.
    View in: PubMed
    Score: 0.432
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES